Team Portfolio Raise Essays

F4/Lilly Ventures/Activity

Lilly Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in SRTD Biotech's oversubscribed EUR 31.5M seed round for mRNA therapeutics, led by Merieux Equity Partners.

SRTD Biotech

SRTD Biotech Lilly Ventures

ddw-online.comNOV 2026

european-biotechnology.com

NOV 2026

News

Lilly Ventures head Brad Robling was named to the 2026 Global Venturing Powerlist of 100 corporate venturing leaders.

Brad Robling named to Global Venturing Powerlist 2026

globalventuring.comJUN 22, 2026

JUN 22, 2026

Investment

Participated in Fathom Therapeutics' $47M Series A, led by Sutter Hill Ventures.

Fathom Therapeutics

Fathom Therapeutics Lilly Ventures

endpoints.newsAPR 2026

APR 2026

Press

European head Laura Lane described Lilly Ventures' syndicate-led seed and Series A strategy at BIO-Europe.

Laura Lane interview with In Vivo on Lilly Ventures

insights.citeline.comMAR 24, 2025

MAR 24, 2025

Investment

Participated in Maxion Therapeutics' $72M oversubscribed Series A.

Maxion Therapeutics

Maxion Therapeutics Lilly Ventures

maxiontherapeutics.comMAR 2025

MAR 2025

New Fund

Lilly and a16z Bio + Health announced a fund of up to $500M, with all capital from Lilly, managed by a16z.

Biotech Ecosystem Venture Fund

a16z.comJAN 14, 2025

JAN 14, 2025

Lilly Ventures | Activity | F4